The ovaries of transgender men indicate effects of testosterone treatment on the ovarian stroma without changes in non-growing follicle density
Molecular Human Reproduction · 06.10.2026 · 32 (4)
DOI: 10.1093/molehr/gaag061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Human Reproduction, online erschienen am 20.10.2026. Verfasst von Emily Bailie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cell Biology, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Testosterone, Ovarian Follicle, Stromal Cells, Ovary. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Medical Research Council (MRC), Wellcome Trust Collaborative Award in Science.
Abstract (Originalsprache)
The ovarian stroma surrounds ovarian follicles and provides a supportive microenvironment during follicle quiescence and subsequent growth. In this study, we investigated the effect of testosterone exposure on human ovarian stromal composition, specifically collagen and elastin content and stromal cell density (SCD), and its relationship with non-growing follicle density (NGFD). Whole ovaries were obtained from transgender men receiving long-term testosterone therapy (mean age 27.6 ± 1.7 years, n = 8) at oophorectomy and compared with ovarian cortical biopsies from age-matched healthy women obtained at caesarean section (mean age 31.8 ± 1.5 years, n = 8). Testosterone-exposed ovarian tissue demonstrated a more fibrotic stromal composition, characterized by increased collagen and reduced elastin, resulting in a higher collagen–elastin ratio indicative of increased intrinsic tissue rigidity. SCD was significantly higher in testosterone-exposed tissue, consistent with stromal cell hyperplasia, whereas NGFD was comparable to controls. These findings indicate that elevated circulating testosterone alters ovarian stromal composition and cellularity without reducing the non-growing follicle pool. Although interpretation is limited by the use of pregnancy-derived control tissue, these findings provide insight into the effects of testosterone on the ovarian microenvironment and warrant further investigation of their functional significance for transgender men considering pregnancy or fertility preservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cell Biology, University of Edinburgh, Edinburgh, UK.
- Department of Gynaecology, Queen Elizabeth University Hospital, Glasgow, UK.
- Simpson Centre for Reproductive Health, Royal Infirmary, Edinburgh, UK.
- Department of Gynaecology, Spire Thames Valley Hospital, Slough, UK.
- Centre for Reproductive Health, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Emily Bailie, Johanne Grosbois, Richard A Anderson, Evelyn E Telfer
Förderung
- Medical Research Council (MRC)
- Wellcome Trust Collaborative Award in Science
Zitieren
APA
Bailie, E., Grosbois, J., Hawthorn, R., Jack, S., Watson, N., Anderson, R. A., & Telfer, E. E. (2026). The ovaries of transgender men indicate effects of testosterone treatment on the ovarian stroma without changes in non-growing follicle density. Molecular Human Reproduction, 32(4). https://doi.org/10.1093/molehr/gaag061
Vancouver
Bailie E, Grosbois J, Hawthorn R, Jack S, Watson N, Anderson RA, et al. The ovaries of transgender men indicate effects of testosterone treatment on the ovarian stroma without changes in non-growing follicle density. Molecular Human Reproduction. 2026;32(4). doi:10.1093/molehr/gaag061
BibTeX
@article{Bailie2026,
author = {Bailie, Emily and Grosbois, Johanne and Hawthorn, Robert and Jack, Stuart and Watson, Neale and Anderson, Richard A and Telfer, Evelyn E},
title = {The ovaries of transgender men indicate effects of testosterone treatment on the ovarian stroma without changes in non-growing follicle density},
journal = {Molecular Human Reproduction},
year = {2026},
volume = {32},
number = {4},
doi = {10.1093/molehr/gaag061}
}
EUVIMED